Chiara Maria Trovato

Digestive Diseases and Nutritional Rehabilitation Unit, Nutritional Treatments of Complex Diseases Research Unit, Bambino Gesù Children's Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00165 Rome, Italy.

50 publications 2020 – 2026 ORCID

What does Chiara Maria Trovato research?

Chiara Maria Trovato studies how various conditions impact children's health, particularly focusing on gastrointestinal disorders such as short bowel syndrome, Crohn's disease, and celiac disease. She explores the effectiveness of different treatments, including dietary changes like gluten-free diets and specialized nutrition plans, to assist children's growth and health. Her work also addresses the diagnostic methods for conditions like breast cancer and the importance of genetic factors in hereditary cancers, ensuring more effective patient management and support.

Key findings

  • In children with celiac disease, 55.7% of those who were underweight achieved normal weight after 12-18 months on a gluten-free diet.
  • In a study on pediatric intestinal pseudo-obstruction, children treated with pyridostigmine showed over 25% improvement in feeding tolerance and some no longer needed IV nutrition after 12 months.
  • The new HPV test for anal cancer screening was 87.7% effective in identifying significant pre-cancerous changes in high-risk patients.
  • Among 20 high-grade invasive breast cancer samples, 80% showed unexpected p63 protein expression, aiding in more accurate diagnoses.
  • For chronic kidney disease patients, personalized nutritional plans are crucial as malnutrition is common, impacting growth and health.

Frequently asked questions

Does Dr. Trovato study celiac disease?
Yes, Dr. Trovato investigates how celiac disease affects children, including their quality of life and nutritional management.
What treatments has Dr. Trovato researched for pediatric patients?
She has researched various treatments, including the effectiveness of gluten-free diets for children with celiac disease and enteral nutrition for those with Crohn's disease.
Is Dr. Trovato's work relevant to children with gastrointestinal disorders?
Absolutely, her research primarily focuses on improving the health outcomes of children suffering from various gastrointestinal disorders.
What is the impact of Dr. Trovato's research on breast cancer diagnoses?
Her studies help healthcare providers accurately diagnose high-grade breast cancer by identifying important proteins that might indicate the disease.
How does Dr. Trovato's research help children with chronic diseases?
Her work focuses on personalized nutritional interventions that are essential for managing conditions like chronic kidney disease and improving overall health.

Publications in plain English

p63 immunohistochemical expression in tumor cells of high-grade invasive breast carcinomas on core biopsy: a potential diagnostic pitfall.

2026

Annals of diagnostic pathology

Salzano S, Vecchio GM, Mazzucchelli M, Furci M, Trovato C +2 more

Plain English
This study looked at a protein called p63 in breast cancer tissues to see how it behaves in different grades of tumors. Among 20 high-grade invasive breast cancers, 80% showed some p63 expression, while lower-grade tumors almost always did not. This matters because recognizing this unexpected p63 presence can help doctors accurately diagnose high-grade breast cancer, especially when examining small biopsy samples. Who this helps: This helps doctors in accurately diagnosing breast cancer.

PubMed

Body Mass Index Status in Italian Children with Celiac Disease at Diagnosis and After 12-18 Months on a Gluten-Free Diet: A Multicenter Retrospective Study.

2026

Nutrients

Monzani A, Pozzi E, Abbattista L, Crocco M, Malerba F +31 more

Plain English
This study looked at the body weight of Italian children diagnosed with celiac disease and how their weight changed after following a gluten-free diet for 12-18 months. Initially, 77.5% of the 4,967 children were normal weight, while 18.1% were overweight or obese. After the diet, 55.7% of those who were underweight reached a normal weight, but only 23% of those who were overweight or obese returned to normal weight, showing that while the gluten-free diet helps many, it is less effective for those already overweight. Who this helps: This helps children with celiac disease and their families by providing insights into how weight may change with dietary management.

PubMed

Pre-, Pro-, Post- and Synbiotics in Pediatric Short Bowel Syndrome: A Narrative Review of Current Evidence.

2026

Children (Basel, Switzerland)

Ruiz RG, Morelli A, Grieco R, Cardile S, Capriati T +6 more

Plain English
This research reviewed the use of prebiotics, probiotics, and synbiotics in treating pediatric short bowel syndrome (SBS), which is a condition causing serious intestinal problems in children. The study looked at 14 different studies and found that long-term use of synbiotics for more than 12 months can improve growth and nutrition in these patients. However, some serious risks were highlighted, particularly for patients with certain medical devices or malabsorption issues, indicating that careful selection and monitoring of treatments are essential. Who this helps: This benefits children with short bowel syndrome, their families, and healthcare providers involved in their care.

PubMed

Malnutrition management in children with chronic kidney disease.

2025

Pediatric nephrology (Berlin, Germany)

Corsello A, Trovato CM, Dipasquale V, Proverbio E, Milani GP +3 more

Plain English
This study focused on how to manage nutrition for children with chronic kidney disease (CKD). Researchers found that malnutrition is common in these children, requiring careful and personalized nutritional plans to support their growth and health, which includes monitoring calorie and protein intake. Proper nutrition is essential to avoid serious health problems and improve the quality of life for these kids. Who this helps: This helps children with chronic kidney disease and their caregivers.

PubMed

Predictive factors of health related quality of life in children and adolescents with celiac disease: An Italian multicenter study on behalf of the SIGENP.

2025

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Crocco M, Malerba F, Calvi A, Zampatti N, Valitutti F +26 more

Plain English
The study looked at how celiac disease affects the quality of life in children and teenagers across 11 centers in Italy, involving 871 families. It found that overall, these young patients reported a "neutral-good" quality of life, with an average score of 47.1 out of 100 on a specific questionnaire, while their parents rated it lower at 45.1. Key factors like being diagnosed without a biopsy and living in Northern Italy were linked to lower quality of life scores, highlighting that some children may struggle more than parents realize. Who this helps: This helps patients with celiac disease and their families by identifying factors that impact their quality of life.

PubMed

predictions of drug-induced changes in human cardiac contractility align with experimental recordings.

2025

Frontiers in pharmacology

Trovato C, Longobardi S, Passini E, Beattie KA, Holmes M +3 more

Plain English
This study looked at how well computer models can predict changes in heart function caused by drugs. The researchers tested 41 different drugs and found that the models were accurate in predicting heart changes for 86% of the drugs that caused a decrease in heart function. This is important because understanding how drugs affect the heart can help prevent harmful side effects and improve drug safety in development. Who this helps: This benefits patients and drug developers by improving drug safety assessments.

PubMed

Paediatric Congenital Enteropathies: Clinical and Histological Review.

2025

Diagnostics (Basel, Switzerland)

Arienzo F, Giovannoni I, Diamanti A, Trovato CM, De Angelis P +3 more

Plain English
This research paper looks at rare inherited diseases called paediatric congenital enteropathies (PCEs), which usually show up in babies and can lead to serious problems if not treated right away. The authors found that understanding these conditions relies on detailed medical examinations and genetic testing, helping healthcare providers diagnose and manage these diseases more accurately. This is important because better diagnosis can lead to better treatment, ultimately saving lives. Who this helps: This helps doctors and healthcare professionals in diagnosing and treating infants with complex gastrointestinal issues.

PubMed

Pyridostigmine improves feeding tolerance in pediatric intestinal pseudo-obstruction: A single-center analysis.

2025

Journal of pediatric gastroenterology and nutrition

Capriati T, De Giorgio R, Chiusolo F, Tambucci R, Fusaro F +4 more

Plain English
This study looked at how pyridostigmine, a medication usually used for adults with gut issues, affects children with a condition called pediatric intestinal pseudo-obstruction (PIPO), which makes it hard for their intestines to work properly. After 12 months of treatment, children using pyridostigmine increased their oral and enteral feeding tolerance by more than 25%, and their growth improved, with an increase in weight scores. Additionally, some kids no longer needed IV nutrition, and there were fewer hospitalizations and infections related to their treatments. Who this helps: This helps children with PIPO and their families by improving nutrition and reducing hospital visits.

PubMed

Clinical performance of the BD Onclarity™ HPV extended genotyping assay for anal cancer screening: a prospective pilot study.

2025

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Iacobone AD, Bottari F, Radice D, Martella S, Soru P +5 more

Plain English
This study examined a new HPV test designed for screening anal cancer in high-risk groups, enrolling 202 participants from Italy. The findings showed that the test correctly identified 87.7% of those with significant pre-cancerous changes (AIN2+) and had a negative predictive value of 93.3%, meaning it was reliable in identifying those without the disease. About 30% of participants were diagnosed with AIN2+, and the most common HPV type found in these cases was HPV16, found in over 70% of patients, which is important for targeted treatments and prevention strategies. Who this helps: This helps patients at high risk for anal cancer by improving early detection and potential treatment outcomes.

PubMed

Enteral Nutrition in Pediatric Crohn's Disease: New Perspectives.

2025

Nutrients

Brindicci VF, Grieco R, Ruiz RG, Cardile S, Capriati T +10 more

Plain English
This study looked at how different types of specialized liquid diets (called enteral nutrition) can help children with Crohn's disease go into remission. The researchers found that polymeric diets were especially effective, achieving remission in up to 85% of cases, making them more beneficial than other diet types. This matters because gaining remission can significantly improve the quality of life for children dealing with this chronic illness. Who this helps: This helps pediatric patients with Crohn's disease.

PubMed

Clinical Implication of CDH1 Mutations in Genetic Testing for Diffuse Gastric Cancer Patients.

2024

Oncology

Corso G, Trovato CM, Petitto S, Girardi A, De Scalzi AM +7 more

Plain English
This study looked at genetic changes (mutations) in a gene called CDH1, which is linked to a type of stomach cancer called diffuse gastric cancer. Researchers found that out of 247 genetic changes they reviewed, about 70% of those not linked to cancer were not meeting the necessary medical criteria for testing, while all changes associated with cancer closely followed the updated guidelines. This is important because it means genetic testing for CDH1 should only be done in families that meet specific criteria, ensuring that resources are focused where they are most needed. Who this helps: This helps patients at risk for hereditary diffuse gastric cancer.

PubMed

Intractable diarrhea in infancy and molecular analysis: We are beyond the tip of the iceberg.

2024

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Diamanti A, Trovato CM, Gandullia P, Lezo A, Spagnuolo MI +7 more

Plain English
The study looked at 69 infants in Italy who suffered from severe, chronic diarrhea that led to malnutrition and couldn’t be treated by standard methods. Researchers found that 62 of these children had genetic disorders linked to their diarrhea, and advancements in testing now allow for genetic defects to be identified in 90% of cases. This research matters because it highlights the importance of collaboration between specialists to better understand and manage this complex health issue. Who this helps: This helps infants with intractable diarrhea and their healthcare providers.

PubMed

Discordance of Biomarker Expression Profile between Primary Breast Cancer and Synchronous Axillary Lymph Node Metastasis in Preoperative Core Needle Biopsy.

2024

Diagnostics (Basel, Switzerland)

Marletta S, Giorlandino A, Cavallo E, Dello Spedale Venti M, Leone G +13 more

Plain English
This study looked at how breast cancer tumors and their lymph node metastases might express different biomarkers, which are indicators used to determine treatment options. Researchers found that 10% of cases showed discrepancies in biomarker expression between the primary tumors and the metastatic lymph nodes, with significant changes in hormone receptors and HER2 levels. This is important because these differences can affect treatment decisions, highlighting the need for careful evaluation of both tumor types before surgery. Who this helps: Patients with breast cancer and their doctors.

PubMed

CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype.

2024

JAMA network open

Corso G, Marino E, Zanzottera C, Oliveira C, Bernard L +21 more

Plain English
This study focused on women with hereditary lobular breast cancer (LBC) to look for specific genetic changes known as CDH1 variants that are linked to a higher risk of certain cancers. Researchers found that 1.5% of the women tested had significant (pathogenic) CDH1 variants, and those with these variants were diagnosed at a younger age (around 42.5 years) compared to others with less harmful variants (around 51 years). This is important because it highlights the need for genetic testing in women with early-onset LBC, especially if they have a family history, which could lead to better screening and prevention strategies. Who this helps: Patients, particularly women with early-onset lobular breast cancer and their families.

PubMed

Prevalence of delivery mode in an Italian nationwide cohort with celiac disease: a SIGENP multicenter retrospective study (the CD-deliver-IT).

2024

Italian journal of pediatrics

Iorfida D, Valitutti F, Vestri A, D'Adamo G, Passaro T +16 more

Plain English
This study looked at how babies were born to a large group of people in Italy with celiac disease. Out of over 3,200 patients, about 40% were born via cesarean section (CS), and those born by emergency CS were diagnosed with celiac disease at a younger age (about 4 years) compared to those born vaginally (about 6 years) or through planned CS (about 7 years). This is important because it suggests that the way a baby is delivered might influence the risk of developing celiac disease and when it shows up, although other factors also play a role. Who this helps: This research benefits doctors and patients by providing insights into potential risks related to delivery methods for celiac disease.

PubMed

Gastric neuroendocrine tumors: 20-Year experience in a reference center.

2024

Journal of neuroendocrinology

Ravizza D, Giunta M, Sala I, Bagnardi V, Tamayo D +10 more

Plain English
This study looked at how doctors have treated gastric neuroendocrine tumors (gNETs) over 20 years, focusing on different treatments and their outcomes. Among 69 patients, most were treated endoscopically, with 293 tumors being removed—74% with forceps, and the other methods showing no significant differences in success rates. Importantly, no patients died from gNETs during the follow-up period, but 60% of those with Type 1 tumors developed new tumors. Who this helps: This benefits patients with gastric neuroendocrine tumors and their doctors by providing insights on effective treatment strategies.

PubMed

In silico evaluation of cell therapy in acute versus chronic infarction: role of automaticity, heterogeneity and Purkinje in human.

2024

Scientific reports

Riebel LL, Wang ZJ, Martinez-Navarro H, Trovato C, Camps J +7 more

Plain English
This study looked at how cell therapy performs in patients with different types of heart damage, specifically acute and chronic myocardial infarction (MI). Researchers found that when cell therapy was applied, varied cell types increased the risk of irregular heartbeats, especially in cases of chronic MI with larger tissue damage. They concluded that using similar types of cells during therapy can reduce unwanted heartbeats, highlighting the importance of healthy connections between heart tissues for better outcomes. Who this helps: This helps patients with heart damage and their doctors by providing insights for safer treatment options.

PubMed

Clinical Presentations of Celiac Disease: Experience of a Single Italian Center.

2024

Nutrients

Trovato CM, Ferretti F, Delli Bovi AP, Elefante G, Ancinelli M +10 more

Plain English
This study looked at how celiac disease (CeD) has presented in children at a hospital in Italy over the past 12 years. They found that diagnoses of CeD increased by 17.5% during this time, with more children showing non-classic symptoms like bloating and abdominal pain, while severe cases of celiac crisis have become less common. This is important because it highlights a shift in how celiac disease appears, which can help doctors better identify and treat patients. Who this helps: This benefits doctors and patients, especially children with celiac disease.

PubMed

Prevalence and detection rate of celiac disease in Italy: Results of a SIGENP multicenter screening in school-age children.

2023

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Lionetti E, Pjetraj D, Gatti S, Catassi G, Bellantoni A +14 more

Plain English
This study looked at how common celiac disease is among school-age children in Italy and how many of those cases are being detected. They found that 1.65% of the children screened had celiac disease, but only 40% of those had been diagnosed before the screening, meaning that 60% were still undetected. This matters because many children are living with this lifelong condition without knowing it, which could impact their health and well-being. Who this helps: This benefits children with celiac disease and their families by increasing awareness and encouraging earlier diagnosis.

PubMed

Early Antibody Dynamics in a Prospective Cohort of Children At Risk of Celiac Disease.

2023

The American journal of gastroenterology

Valitutti F, Leonard MM, Kenyon V, Montuori M, Piemontese P +19 more

Plain English
This study looked at blood tests in children who are at risk of developing celiac disease to find early signs that the disease might start. Out of 325 children, 38 developed a specific antibody related to celiac disease, and 73.6% of these children showed an increase in another antibody before the disease was officially diagnosed. This finding is important because it could help identify celiac disease earlier, allowing for proactive management. Who this helps: Patients at risk of celiac disease and their families.

PubMed

Cohort profile: Celiac disease genomic, environmental, microbiome and metabolome study; a prospective longitudinal birth cohort study of children at-risk for celiac disease.

2023

PloS one

Leonard MM, Kenyon V, Valitutti F, Pennacchio-Harrington R, Piemontese P +8 more

Plain English
This study followed children who are at high risk for celiac disease because they have a family member with it. Over nearly nine years, researchers found that 54 of the 554 participants developed signs of the disease, with many showing symptoms by age three. They discovered changes in gut bacteria and metabolites before the disease started, which could help predict who will develop celiac disease and how it might be prevented. Who this helps: This research benefits children at risk for celiac disease and their families by providing insights that could lead to better monitoring and prevention strategies.

PubMed

Role of age in dynamics of autoantibodies in pediatric Celiac disease.

2023

Italian journal of pediatrics

Trovato CM, Montuori M, Leter B, Laudadio I, Russo G +1 more

Plain English
This study looked at how age affects the levels of specific antibodies in children diagnosed with celiac disease (CD). Researchers found that children with very high antibody levels (10 times the normal limit) were diagnosed much younger, at a median age of 4.4 years, compared to those with lower levels who were diagnosed at 8.5 to 9.5 years. This highlights that younger children may show stronger signs of autoimmunity, which is important for early diagnosis and treatment of celiac disease. Who this helps: This helps doctors by providing insights for earlier detection of celiac disease in young children.

PubMed

Enteral formula compared to Nissen-Fundoplication: Data from a retrospective analysis on tolerance, utility, applicability, and safeness in children with neurological diseases.

2023

Frontiers in nutrition

Trovato CM, Capriati T, Bolasco G, Brusco C, Santariga E +8 more

Plain English
This study looked at how different treatments for gastrointestinal issues affect children with neurological disorders. Researchers compared two approaches: enteral feeding (using specialized diets) and Nissen Fundoplication, a type of surgery. They found that while the surgery group had fewer hospital visits for non-gastrointestinal problems, they needed more visits for gastrointestinal issues and had higher rates of symptoms like vomiting and swallowing difficulties. Importantly, enteral feeding may be a better first option because it can meet nutritional needs without the additional stress of surgery. Who this helps: This research benefits children with neurological disorders and their families by providing insights into treatment options for gastrointestinal problems.

PubMed

Neurological impairment and malnutrition in children: The role of home enteral nutrition in real life.

2023

Frontiers in nutrition

Diamanti A, Capriati T, Mosca A, Trovato CM, Laureti F +9 more

Plain English
This study looked at how home enteral nutrition (HEN) affects the health of children with neurological impairments, focusing on their nutritional status and digestive issues. Researchers analyzed data from 402 children over eight years and found that after starting HEN, 97% of the children survived, and their growth improved significantly within the first two years, with reductions in gastroesophageal reflux disease (GERD) and airway aspiration. This is important because it shows that proper nutrition can enhance growth and help reduce some health problems in these vulnerable children. Who this helps: This study helps children with neurological impairments and their caregivers.

PubMed

Ketogenic diet in children and adolescents: The effects on growth and nutritional status.

2023

Pharmacological research

Corsello A, Trovato CM, Di Profio E, Cardile S, Campoy C +3 more

Plain English
This study looked at how the ketogenic diet, which is high in fats and low in carbohydrates, affects the growth and nutrition of children and teenagers. Researchers found that while the diet might help with certain medical conditions like epilepsy, its long-term impact on growth and nutrition in young people is still unclear. This matters because if a child goes on this diet, it could lead to nutritional imbalances and affect their overall development. Who this helps: Parents and healthcare providers considering the ketogenic diet for children with specific medical conditions.

PubMed

Vitamin D Supplementation and Adherence to World Cancer Research Fund (WCRF) Diet Recommendations for Colorectal Cancer Prevention: A Nested Prospective Cohort Study of a Phase II Randomized Trial.

2023

Biomedicines

Serrano D, Bellerba F, Johansson H, Macis D, Aristarco V +8 more

Plain English
This research studied the effects of Vitamin D supplementation and adherence to a healthy diet recommended by the World Cancer Research Fund on colorectal cancer (CRC) prevention in 74 CRC patients. The study found that patients who followed the recommended diet had a significantly lower risk of CRC-related events, with a risk reduction of about 59% over an average follow-up of 2.6 years. However, Vitamin D supplementation alone did not change related health markers or event rates, suggesting that a healthy diet and lifestyle are crucial for cancer prevention. Who this helps: This helps patients at risk for colorectal cancer and healthcare providers focused on prevention strategies.

PubMed

The Influence of Ketogenic Diet on Gut Microbiota: Potential Benefits, Risks and Indications.

2023

Nutrients

Santangelo A, Corsello A, Spolidoro GCI, Trovato CM, Agostoni C +3 more

Plain English
This study looked at how a ketogenic diet (KD), which is low in carbohydrates and high in fats, affects gut bacteria. The researchers reviewed 30 years of studies and found that while KD can help with weight loss, blood sugar control, and some neurological conditions, it might also upset the balance of gut bacteria, leading to potential health risks. Knowing how KD impacts gut microbiota is important because it can affect overall health, especially in young people. Who this helps: This information benefits patients considering the ketogenic diet, especially adolescents and young adults.

PubMed

Refeeding Syndrome in Pediatric Age, An Unknown Disease: A Narrative Review.

2023

Journal of pediatric gastroenterology and nutrition

Corsello A, Trovato CM, Dipasquale V, Bolasco G, Labriola F +4 more

Plain English
This study focused on refeeding syndrome (RS), a serious condition that can affect children who are malnourished and suddenly given food again. It found that up to 7.4% of children in intensive care units who receive nutritional support may develop RS, which can cause dangerous symptoms like weakness and seizures. The research emphasizes the importance of slowly increasing food intake and monitoring electrolyte levels to prevent this condition and ensure safe recovery. Who this helps: This helps doctors and healthcare providers caring for malnourished children.

PubMed

Investigating the Relationship Between COVID-19 and Celiac Disease. A Dual Research Approach.

2023

JPGN reports

Tiberti C, Bonamico M, Nenna R, Petrarca L, Trovato CM +6 more

Plain English
This study looked at how COVID-19 relates to celiac disease in children and adolescents. Researchers tested 78 kids with celiac disease for COVID-19 antibodies and found that 7.7% had them, which is similar to the 9.2% found in 141 healthy kids. They also checked 97 kids who had COVID-19 and found that none developed specific antibodies related to celiac disease, suggesting that COVID-19 does not trigger this autoimmune condition in the months after infection. Who this helps: Patients with celiac disease and their families, as well as doctors treating them.

PubMed

Maintenance Therapy With the Lowest Effective Dose of Oral Viscous Budesonide in Children With Eosinophilic Esophagitis.

2022

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Oliva S, Volpe D, Russo G, Veraldi S, Papoff P +5 more

Plain English
This study looked at how to effectively use the lowest dose of a medication called oral viscous budesonide to help children with eosinophilic esophagitis (EoE), a condition causing difficulty in swallowing and inflammation in the esophagus. Researchers focused on whether reducing the medication dose after successful initial treatment could still keep symptoms under control, but found that there's no clear strategy yet for how long children should be treated or if everyone can use lower doses safely. This matters because finding the right maintenance dose can help avoid unnecessary medication and side effects for kids with EoE. Who this helps: This helps children with eosinophilic esophagitis and their healthcare providers.

PubMed

A new double immunohistochemistry method to detect mucosal anti-transglutaminase IgA deposits in coeliac children.

2022

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Trovato CM, Oliva S, Pietropaoli N, Pignataro MG, Berni S +4 more

Plain English
This study looked at a new method to detect specific deposits in the intestines of children with coeliac disease, which can help identify the condition early. Researchers analyzed tissue samples from 61 children: 32 with clear coeliac disease, 14 at risk for developing it, and 15 without the disease. They found that all children with coeliac disease had these deposits, while only some of those at risk had them, and none were found in healthy children. This method could lead to better and earlier diagnosis of coeliac disease, which is important for managing the condition effectively. Who this helps: This helps children with coeliac disease and their doctors.

PubMed

Impact of colonoscopy on working productivity: a prospective multicenter observational study.

2022

Gastrointestinal endoscopy

Fuccio L, Collatuzzo G, Frazzoni L, Cadoni S, Anderloni A +24 more

Plain English
Researchers studied how colonoscopy affects people's ability to work. They found that about 30.5% of the 1,137 patients experienced issues that affected their productivity, particularly due to the bowel preparation process and pain during the procedure. For example, those on a full-dose prep were more than four times more likely to have impaired performance compared to those on a split-dose regimen. This is important because understanding these effects can help schedule colonoscopies in a way that minimizes disruption to patients' work lives. Who this helps: Patients who need a colonoscopy and want to maintain their work productivity.

PubMed

germline mutations in healthy individuals from families with the hereditary diffuse gastric cancer syndrome.

2022

Journal of medical genetics

Corso G, Magnoni F, Massari G, Trovato CM, De Scalzi AM +5 more

Plain English
This study looked at genetic mutations in healthy people from families known to have hereditary diffuse gastric cancer. Researchers found that 30.4% of healthy individuals had certain mutations called splicing mutations, compared to only 15.2% of patients with gastric cancer. This indicates that some mutations may not increase the risk of cancer as much as others, which is important for understanding who might be at risk. Who this helps: This helps patients and healthcare providers in assessing cancer risk more accurately.

PubMed

Five-Year Inpatient Management of Teenagers With Anorexia Nervosa: Focus on Nutritional Issues.

2022

Journal of pediatric gastroenterology and nutrition

Trovato CM, Capriati T, Bolasco G, Campana C, Papa V +6 more

Plain English
This study looked at how to effectively treat teenagers with Anorexia Nervosa (AN) in the hospital, focusing on nutritional interventions. They found that using a combination of natural feeding, oral nutritional supplements, and nasogastric feeding helped patients gain weight faster, reducing hospital stays by an average of over 20 days for those who needed intensive nutritional support. This is important because malnutrition is a major reason for hospitalization, and over half of the patients were severely malnourished. Who this helps: This helps teenagers with Anorexia Nervosa and their healthcare providers.

PubMed

Real food in enteral nutrition for chronically ill children: overview and practical clinical cases.

2022

Current medical research and opinion

Dipasquale V, Diamanti A, Trovato CM, Elia D, Romano C

Plain English
This paper looked at how using real food in tube feeding can help chronically ill children. Researchers observed four clinical cases using a new formula made from ingredients like peas, green beans, peaches, carrots, and chicken, which provides 1.2 kcal per milliliter. The study found that this real food formula improved how well kids tolerated their feedings and made mealtime more engaging for families, highlighting the importance of personalized nutrition in medical care. Who this helps: This benefits patients and their families, as well as doctors managing their nutrition.

PubMed

Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations.

2022

Seminars in oncology

Corso G, Magnoni F, Nicastro V, Bagnardi V, Trovato CM +1 more

Plain English
Researchers looked at the results of preventive surgeries called prophylactic total gastrectomy for people with specific genetic mutations linked to a high risk of stomach cancer. They found that out of 224 surgeries, cancer was found in 85.4% of cases after the surgery, with the United States reporting a notable 19.6% having no cancer at all afterward. This study highlights the importance of total gastrectomy as a crucial treatment for those with these genetic mutations, helping to catch cancer early and save lives. Who this helps: This benefits patients with E-cadherin mutations and their families.

PubMed

Determinants of symptom burden related to bowel preparation for colonoscopy.

2022

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Collatuzzo G, Fuccio L, Frazzoni L, Radaelli F, Hassan C +22 more

Plain English
Researchers studied the factors that cause discomfort during bowel preparation for colonoscopy, involving over 1,100 patients from 10 hospitals in Italy. They found that women were more likely to experience severe symptoms (about 3.6 times more than men), especially those with a history of gastrointestinal issues and intense work schedules. Understanding these factors is important because it can help improve the experience for patients and encourage more people to undergo this crucial screening. Who this helps: This helps patients and doctors by identifying those at higher risk for experiencing discomfort during bowel preparation.

PubMed

Management of Nutritional Needs in Pediatric Oncology: A Consensus Statement.

2022

Cancers

Fabozzi F, Trovato CM, Diamanti A, Mastronuzzi A, Zecca M +9 more

Plain English
This research focused on how to manage the nutritional needs of children with cancer, as malnutrition—whether too much or too little—affects their health and survival. The study involved experts from four Italian centers, who developed recommendations based on answers to 21 key questions about nutrition in pediatric oncology and reached a consensus on how to address these issues. Their findings are crucial because they provide clear guidelines that can improve the overall health and growth of children undergoing cancer treatment. Who this helps: This helps patients, their families, and healthcare providers involved in pediatric oncology.

PubMed

Incidence, risk and protective factors of symptoms after colonoscopy.

2022

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Collatuzzo G, Boffetta P, Radaelli F, Cadoni S, Hassan C +22 more

Plain English
This study looked at how common it is for people to experience gastrointestinal symptoms after having a colonoscopy, and what might contribute to these symptoms. Out of 793 patients, about 45.5% reported at least one new symptom, with the most common issues being bloating (32.2%), pain (17.3%), and digestive problems (17.9%). The findings highlight that women, particularly those in a bad mood, are at a higher risk of developing these symptoms, suggesting that helping patients prepare better for the procedure could reduce discomfort afterward. Who this helps: This helps patients undergoing colonoscopies, especially women and those who might be feeling anxious or unwell.

PubMed

Cross clinical-experimental-computational qualification ofdrug trials on human cardiac purkinje cells for proarrhythmia risk prediction.

2022

Frontiers in toxicology

Trovato C, Mohr M, Schmidt F, Passini E, Rodriguez B

Plain English
This study looked at how well drug tests predict the risk of heart rhythm problems (proarrhythmia) using human heart cells, specifically Purkinje cells. They tested 14 different drugs and found that the simulations using human heart cells were more accurate than tests done on rabbits, leading to better predictions of arrhythmia risk. This is important because using human models could improve drug safety assessments and help prevent harmful side effects in patients. Who this helps: Patients and doctors involved in medication management and safety.

PubMed

Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients.

2022

Neoplasia (New York, N.Y.)

Bellerba F, Serrano D, Harriet J, Pozzi C, Segata N +17 more

Plain English
This study looked at how vitamin D and gut bacteria might affect colorectal cancer (CRC) patients after treatment. Out of 74 patients, those who received 2,000 IU of vitamin D daily for a year had notable changes in gut bacteria, and the presence of certain bacteria was linked to how well patients did. For example, women who were given vitamin D showed more growth of specific bacteria that may be important for their recovery. Who this helps: This research benefits colorectal cancer patients, particularly women, by highlighting the importance of vitamin D and gut health in their recovery.

PubMed

Pharmacokinetics of oral mannitol for bowel preparation for colonoscopy.

2022

Clinical and translational science

Fiori G, Spada C, Soru P, Tontini GE, Bravi I +12 more

Plain English
This study looked at how well different doses of oral mannitol work as a preparation for colonoscopy by measuring how much of the drug gets into the bloodstream. They found that when patients took doses of 50, 100, or 150 grams, the amount of mannitol in their blood increased based on the dose: for example, the average concentration was 0.63 mg/ml for 50 grams and 1.36 mg/ml for 150 grams. Overall, about 20% of the mannitol was absorbed into the body, which is important to consider when deciding how much to use to prepare for a colonoscopy to avoid unwanted side effects. Who this helps: This helps patients preparing for colonoscopy.

PubMed

Microbiome as Mediator of Diet on Colorectal Cancer Risk: The Role of Vitamin D, Markers of Inflammation and Adipokines.

2021

Nutrients

Serrano D, Pozzi C, Guglietta S, Fosso B, Suppa M +13 more

Plain English
This study looked at how our gut bacteria, or microbiome, connect diet and the risk of colorectal cancer (CRC). Researchers found that people with CRC were more likely to have low vitamin D levels and that a diet low in fatty fish and high in carbohydrates increased CRC risk. The analysis also revealed that a healthier gut microbiome could reduce the impact of poor diet on this cancer risk. Who this helps: This information benefits patients at risk for colorectal cancer and healthcare providers seeking to prevent it.

PubMed

Association between Elevated TGA-IgA Titers and Older Age at Diagnosis with Absence of HBV Seroconversion in Celiac Children.

2021

Vaccines

Trovato CM, Montuori M, Sansone A, Morelli A, Russo G +2 more

Plain English
This study looked at children with celiac disease and found that 41.7% of them had low or no protective antibodies against hepatitis B after vaccination. It discovered that higher levels of a specific antibody (TGA-IgA) and being older at the time of diagnosis made it less likely for these children to develop immunity to the hepatitis B vaccine. This is important because it highlights a need for better monitoring and possible revaccination for these patients to ensure they are protected against hepatitis B. Who this helps: This helps celiac disease patients and their healthcare providers.

PubMed

Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off-label in the first wave of COVID-19.

2021

Clinical and translational science

Delaunois A, Abernathy M, Anderson WD, Beattie KA, Chaudhary KW +15 more

Plain English
This research studied the potential risks of heart problems when using the antimalarial drugs chloroquine (CLQ) and hydroxychloroquine (OH-CLQ), especially when combined with antibiotics erythromycin (ERT) and azithromycin (AZI) during the COVID-19 pandemic. The findings showed that both CLQ and OH-CLQ can disrupt heart rhythms, increasing the risk of serious heart conditions like Torsades de Pointes, particularly in individuals with existing heart risks; CLQ was found to be more harmful than OH-CLQ. This matters because it highlights the potential dangers of using these medications, especially in vulnerable patient groups. Who this helps: This helps patients, especially those with underlying heart conditions or those taking these medications.

PubMed

Diagnostic Value of Persistently Low Positive TGA-IgA Titers in Symptomatic Children With Suspected Celiac Disease.

2021

Journal of pediatric gastroenterology and nutrition

Trovato CM, Montuori M, Morelli A, Alunni Fegatelli D, Vestri A +4 more

Plain English
This study looked at how effective low levels of a specific antibody (TGA-IgA) are in diagnosing celiac disease (CD) in children showing symptoms. Out of 162 kids with low TGA-IgA values, 87.7% were diagnosed with CD, and 100% of kids with moderate levels were diagnosed. These findings highlight that low or moderate TGA-IgA levels are reliable indicators for CD, indicating that children with these measurements should get further testing regardless of other antibody results. Who this helps: This helps doctors diagnosing celiac disease in children.

PubMed

COVID-19 and celiac disease: A pathogenetic hypothesis for a celiac outbreak.

2021

International journal of clinical practice

Trovato CM, Montuori M, Pietropaoli N, Oliva S

Plain English
This study looks at the link between COVID-19 and celiac disease, suggesting that the virus may trigger celiac disease in people who are already at risk. Researchers found that COVID-19 can damage the gut lining, allowing gluten (from foods like wheat) to enter the body, which may activate celiac disease. This is important because it means that those with a genetic risk for celiac disease might face a higher chance of developing it after getting COVID-19. Who this helps: This information benefits patients at risk of celiac disease, doctors, and healthcare providers.

PubMed

Microbiome signatures of progression toward celiac disease onset in at-risk children in a longitudinal prospective cohort study.

2021

Proceedings of the National Academy of Sciences of the United States of America

Leonard MM, Valitutti F, Karathia H, Pujolassos M, Kenyon V +16 more

Plain English
This study looked at how the gut bacteria of infants who are at risk for celiac disease change before the disease develops. Researchers followed 20 infants—10 who later developed celiac disease and 10 who did not—over time. They found that certain microbial strains and metabolites changed in abundance and could act as early warning signs for the onset of celiac disease. This research is important because it can help develop strategies to prevent celiac disease in at-risk children. Who this helps: This helps at-risk infants and their families by providing insights into early indicators of celiac disease.

PubMed

The surprising 'Coeliac Chinese box' from Italy.

2021

Gastroenterology report

Trovato CM, Montuori M, Morelli A, Lionetti E, Naspi-Catassi G +3 more

PubMed

ESPGHAN 'biopsy-sparing' guidelines for celiac disease in children with low antitransglutaminase during COVID-19.

2020

European journal of gastroenterology & hepatology

Trovato CM, Montuori M, Cucchiara S, Oliva S

Plain English
This study looked at whether children with a specific range of blood test results for celiac disease could be diagnosed without needing a biopsy during the COVID-19 pandemic, when many routine procedures were delayed. Researchers found that out of 430 diagnosed celiac patients, 84 had test results suggesting they could be diagnosed without a biopsy, and 93% of these kids showed improvement after starting a gluten-free diet. This matters because it means that more children can receive timely treatment for celiac disease without undergoing invasive procedures during health crises. Who this helps: This helps children suspected of having celiac disease and their families.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.